| Literature DB >> 25989228 |
Qiu-Yue Qi1, Er-Wei Li2, Jun-Jie Han2, Yun-Fei Pei2, Ke Ma2, Li Bao2, Ying Huang3, Feng Zhao4, Hong-Wei Liu2.
Abstract
Four new ambuic acid derivatives (1-4), and four known derivatives (5-8), were isolated from the solid culture of a plant pathogenic fungus Pestalotiopsis neglecta. Their structures were elucidated by extensive NMR experiments. The absolute configuration of the C-16 secondary alcohol in 1 was deduced via the CD data of the in situ formed [Rh2(OCOCF3)4] complex with the acetonide derivative of 1. The absolute configuration in 3 was assigned by comparison of the experimental and simulated electronic circular dichroism (ECD) spectrum. The NMR data of compound 5 was reported for the first time. In the nitric oxide (NO) inhibition assay, compounds 4, 6 and 7 showed inhibitory activity against the NO production in the lipopolysaccharide (LPS)-induced macrophage with IC50 values of 88.66, 11.20, and 20.80 µM, respectively.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25989228 PMCID: PMC4437027 DOI: 10.1038/srep09958
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Chemical structures of compounds 1–8.
1H and 13C NMR spectroscopic data of compounds 1–3 in CD3ODa
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| 1 | 171.1 | 172.7 | 171.7 | |||
| 2 | 131.9 | 134.1 | 131.3 | |||
| 3 | 136.6 | 6.70, t (7.6) | 135.3 | 6.64, t (7.0) | 139.0 | 7.14, t (6.8) |
| 4 | 28.8 | 2.76, dd (15.9, 7.6) | 28.7 | 2.74, dd (15.9, 7.0) | 35.4 | 2.70, dd (15.1, 6.8) |
| 2.82, dd (15.9, 7.6) | 2.81, dd (15.9, 7.0) | 2.91, dd (15.1, 6.8) | ||||
| 5 | 61.2, | 61.3 | 74.2 | |||
| 6 | 61.1 | 3.76, d (2.8) | 61.1 | 3.76, d (2.7) | 74.0 | 3.81, d (2.3) |
| 7 | 65.9 | 4.83, br s | 65.9 | 4.82, br s | 72.5 | 4.27, d (2.3) |
| 8 | 150.8 | 151.0 | 132.7 | |||
| 9 | 131.9 | 131.8 | 135.1 | |||
| 10 | 196.0 | 196.1 | 72.4 | 4.09, s | ||
| 11 | 122.9 | 6.16, d (15.9) | 123.6 | 6.15 d (16.0) | 127.2 | 6.49, d (15.8) |
| 12 | 139.9 | 5.86, dt (15.9, 7.0) | 139.1 | 5.83, dt (16.0, 7.0) | 135.2 | 6.04, dt (15.8, 7.0) |
| 13 | 34.5 | 2.19, m | 33.7 | 2.17, m | 34.6 | 2.20, m |
| 14 | 26.4 | 1.52, m | 24.1 | 1.69, m | 30.2 | 1.47, m |
| 15 | 39.6 | 1.47, m | 43.4 | 2.53, t (7.2) | 32.6 | 1.34, m |
| 16 | 68.4 | 3.73, q (6.2) | 211.8 | 23.6 | 1.35, m | |
| 17 | 23.5 | 1.15, d (6.2) | 29.9 | 2.14, s | 14.4 | 0.92, t (7.0) |
| 18 | 60.3 | 4.41, d (12.9) 4.52, d (12.9) | 60.3 | 4.41, d (12.9) 4.51, d (12.9) | 59.9 | 4.29, d (12.2) 4.46, d (12.2) |
| 19 | 12.8 | 1.87, s | 12.9 | 1.87, s | 12.9 | 1.91, s |
a1H-NMR was recorded at 500 MHz; 13C-NMR was recorded at 125 MHz.
bExtracted from HSQC, HMBC data.
Figure 2Key HMBC correlations of compounds 1–5.
Figure 3CD spectrum of Rh-complex of 1a with the inherent contributions subtracted.
Figure 4The experimental CD spectrum of 3 in methanol and the calculated ECD spectra of 9a and 9b.
Structures 9a and 9b represent two possible stereoisomers of 9.
1H and 13C NMR spectroscopic data of compounds 4 and 5 in CD3ODa
| No. | 4 | 5 | ||
|---|---|---|---|---|
| 1 | 171.3 | 171.3 | ||
| 2 | 132.0 | 131.9 | ||
| 3 | 137.1 | 6.85, t (7.5) | 137.2 | 6.86, t (7.5) |
| 4 | 31.7 | 2.62, dd (15.8, 7.5) | 31.8 | 2.63, dd (15.8, 7.5) |
| 3.01, dd (15.8, 7.5) | 3.01, dd (15.8, 7.5) | |||
| 5 | 62.1 | 62.2 | ||
| 6 | 60.7 | 3.35, br s | 60.8 | 3.35, br s |
| 7 | 67.2 | 4.64, br s | 67.5 | 4.68, br s |
| 8 | 128.3 | 132.4 | ||
| 9 | 136.6 | 133.9 | ||
| 10 | 67.0 | 4.48, s | 67.0 | 4.48, s |
| 11 | 126.9 | 6.32, d (15.8) | 127.0 | 6.40, d (15.8) |
| 12 | 135.8 | 6.01, dt (15.8, 7.0) | 134.8 | 5.99, dt (15.8, 7.0) |
| 13 | 34.4 | 2.17, m | 34.5 | 2.17, m |
| 14 | 30.0 | 1.45, m | 30.2 | 1.45, m |
| 15 | 32.5 | 1.33, m | 32.6 | 1.33, m |
| 16 | 23.6 | 1.33, m | 23.6 | 1.34, m |
| 17 | 14.4 | 0.91, t (6.9) | 14.4 | 0.91, t (6.9) |
| 18 | 60.7 | 4.86 | 58.2 | 4.35, s |
| 19 | 12.8 | 1.87, s | 12.8 | 1.87, s |
| 20 | 172.9 | |||
| 21 | 20.8 | 2.03, s | ||
a1H-NMR was recorded at 500 MHz; 13C-NMR was recorded at 125 MHz.
bSignal overlapped with water.
NO inhibitory activity of compounds 1, 4–8 (IC50, μM)
| Compounds | NO inhibitory Activity |
|---|---|
| >100 | |
| 88.66 ± 6.74 | |
| >100 | |
| 11.20 ± 0.79 | |
| 20.80 ± 1.41 | |
| >100 | |
| Positive control | Hydrocortisone |
| 53.68 ± 3.86 |
aThe growth of RAW cells were not influenced by tested compounds at the concentration of 100 μM.